Kejadian Ekstravasasi Obat Kemoterapi pada Pasien Kanker

Marisa Junianti Manik

Abstract

Chemotherapy is a cancer management with drugs. The complication that can be occurred is extravasation. The objective of this study was to analyze factors such as vein conditions, type of medications/chemotherapeutic agents, volume of chemotherapeutic agents, and their correlation with chemotherapy drugs extravasation incidences. This study used cross-sectional observational analytic design, with purposive sampling. The sample of this study was 70 cancer patients undergoing chemotherapy in hospitals. Inclusive criteria were patients with ages 18-65 in their first to fifth cycle of chemotherapy. The observation form was used as research instrument. The study showed that there were no correlation between vein conditions, type of medications/chemotherapeutic agents, and volume of chemotherapeutic agents with extravasation. Most veins were still in good condition while undergoing chemotherapy. The length of time for administering chemotherapy were mostly <24 hours, which contributed for reducing risk for extravasation, although the type of medication used were irritants and vesicants, and with drugs volume of 100–1000 milliliter. The incidences of extravasation that were immediately can be observed during chemotherapy occurred 7.14% of the time. It was possibly occurred by medical devices used, such as infusion pump that was facilitated the nurses in early anticipate drugs leakage outside the veins tissue. Nurses’ roles also contributed to reduced extravasation risks. As conclusion, the results shown there were no correlation statistically; however there might be other contributing factors that need to be explored furthermore.

Keywords

extravasasion; ekstravasasi; agent; chemotherapy; cancer

Full Text:

PDF

References

American Cancer Society. (2013). Chemoterapy What it is, how it helps. www. cancer.org

Cicilia, Manik, M., & Florensa, M. (2014). Faktor risiko dan kejadian ekstravasasi obat kemoterapi. Nursing Current Journal, 2(2), 46-52

Dahlan, M. Sopiyudin. (2010). Besar sampel dan cara pengambilan sampel dalam penelitian kedokteran dan kesehatan. Jakarta: Salemba Medika

Dougherty, L and Catherine O. (2011). Advanced practice in the management of extravasation. Cancer nursing practice. 10 (5) 16 - 22

Gonzalez, T. (2013). Chemoterapy extravasations: prevention, identification, management and documentation. Clinical Journal of Oncology Nursing. Volume 17, Number 1, page 61-66

Kreidieh F, Hiba M, Nagi S. (2016). Overview, prevention and management of chemotherapy extravasation. World Journal of Clinical Oncology. 7(1): 87-97

Lewis, S. (2010). Medical Surgical Nursing: Assessment and management of clinical problem. 8th Edition. Mosby: Elsevier Science

Marelli, TM. (2008). Buku saku dokumentasi keperawatan. Jakarta: EGC

Miller, G. (2008). Pencegahan dan pengobatan penyakit kanker. Jakarta: Prestasi Pustaka

Mouridsen, et.al. (2007). Treatment of anthracycline extravasation with Savene (dexrazoxane). Annals of Oncology 18(3): 546-550

Mubarak, C. (2013). Faktor risiko yang mempengaruhi kejadian extravasasi kemoterapi intravena perifer di RSUP Dr. Sardjito Yogyakarta Tahun 2011-2013. http://etd.ugm.ac.id/index.php?mod=penelitian_detail⊂=PenelitianDetail&act=view&typ=html&buku_id=63348&obyek_id=4

Oestreicher, P. (2007). Can you recognize the risk factors for the vesicant extravasation?. ONS Connect. 22, 1, 22 – 23

Otto. SE. (2005). Keperawatan onkologi. Jakarta: EGC

Polit & Beck. (2006). Essentials of nursing research: methods, appraisal, and utilization. 6th ed. Philadelphia: Lippincott Williams & Wilkins.

Sakaida, E. et. al. (2014). Incidence, risk factors and treatment outcomes of extravasation of cytotoxic agents in an outpatient chemotherapy clinic. Japanese Journal of Clinical Oncology. 44(2) 168 – 171

Sauerland C, Engelking C, Wickham R, Corbi D (2006). Vesicant extravasation part I: mechanisms, pathogenesis, and nursing care to reduce risk. Oncol Nurs Forum. 33(6) 1134-41

Schulmeister, L. (2007). Managing vesicant extravasations. The Oncologist. 13, 284 – 288

World Health Organization. (2015). Media centre: Cancer. http://www.who.int/mediacentre/factsheets/fs297/en/#

Yulia, T. (2012). Gambaran tingkat pengetahuan pasien tentang pengobatan kemoterapi di rumah sakit kanker Dharmais. http://lontar.ui.ac.id

Refbacks

  • There are currently no refbacks.